2009•Unpublished venueRequires access

Surveillance on MIC of Antibiotic Resistance of Meticillin-resistant Staphylococcus aureus

Lianfeng Wu

Open publisher page 0 citations

Abstract

OBJECTIVE To review and analyze the change in the MICs of vancomycin,teicoplanin and linezolid in meticillin-resistant Staphylococcus aureus(MRSA) strains isolated in our hospital from 2003 to 2007. METHODS The MICs of vancomycin,teicoplanin and linezolid were tested by Etest method on a sample of randomly selected MRSA strains. RESULTS The incidences of MRSA increased from 52.2% in 2003 to 74.5% in 2007.MIC of vancomycin increased from 1.85 μg/ml in 2003 to 2.15 μg/ml in 2007,and teicoplanin MIC geometric mean increased even more markedly from 1.28 μg/ml in 2003 to 2.07 μg/ml in 2007.The linezolid MIC remained almost unchanged. CONCLUSIONS The incidences of MRSA were increasing from 2003 to 2007.There is a upward trend in MIC of glycopeptide over the years,in which the increase for teicoplanin is higher than others two.

About this research paper

What this paper is about

OBJECTIVE To review and analyze the change in the MICs of vancomycin,teicoplanin and linezolid in meticillin-resistant Staphylococcus aureus(MRSA) strains isolated in our hospital from 2003 to 2007. METHODS The MICs of vancomycin,teicoplanin and linezolid were tested by Etest method on a sample of randomly selected MRSA strains. RESULTS The incidences of MRSA increased from 52.2% in 2003 to 74.5% in 2007.MIC of vancomycin increased from 1.85 μg/ml in 2003 to 2.15 μg/ml in 2007,and teicoplanin MIC geometric mean increased even more markedly from 1.28 μg/ml in 2003 to 2.07 μg/ml in 2007.The linezolid MIC remained almost unchanged. CONCLUSIONS The incidences of MRSA were increasing from 2003 to 2007.There is a upward trend in MIC of glycopeptide over the years,in which the increase for teicoplanin is higher than others two.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To review and analyze the change in the MICs of vancomycin,teicoplanin and linezolid in meticillin-resistant Staphylococcus aureus(MRSA) strains isolated in our hospital from 2003 to 2007. METHODS The MICs of vancomycin,teicoplanin and linezolid were tested by Etest method on a sample of randomly selected MRSA strains. RESULTS The incidences of MRSA increased from 52.2% in 2003 to 74.5% in 2007.MIC of vancomycin increased from 1.85 μg/ml in 2003 to 2.15 μg/ml in 2007,and teicoplanin MIC geometric mean increased even more markedly from 1.28 μg/ml in 2003 to 2.07 μg/ml in 2007.The linezolid MIC remained almost unchanged. CONCLUSIONS The incidences of MRSA were increasing from 2003 to 2007.There is a upward trend in MIC of glycopeptide over the years,in which the increase for teicoplanin is higher than others two.

Key concepts: Teicoplanin, Linezolid, Etest, Vancomycin, Staphylococcus aureus, Glycopeptide, Microbiology, Methicillin-resistant Staphylococcus aureus

Related papers

Back to paper searchBrowse research topicsOriginal source
Surveillance on MIC of Antibiotic Resistance of Meticillin-resistant Staphylococcus aureus — Research Paper | ScholarLens